European venture capital shop Forbion Capital Partners said today that it raised a $208 million fund it plans to use for investments in medical device, drug and diagnostic companies. The €183 million fund’s limited partners included strategic investors Charles River Laboratories and Knight Therapeutics, plus the European Investment Fund, the Dutch Venture Initiative, Germany’s KfW development bank, other regional investment […]